Delphi Private Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Delphi Private Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$1K	Buy	+11	New	+$1.09K	0.01%	94

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Delphi Private Advisors's TARO Position: Q2 2019 in Review

Delphi Private Advisors opened a new position in Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2019: 11 shares worth $1K. The stake represents 0.01% of the portfolio and ranks #94 among its holdings.

105 funds tracked by Wall St. Rank hold TARO as of Q2 2019.

Delphi Private Advisors held 11 shares of Taro Pharmaceutical Industries Ltd. worth $1K as of Q2 2019.
Taro Pharmaceutical Industries Ltd. was a new Delphi Private Advisors position in Q2 2019.
Taro Pharmaceutical Industries Ltd. made up 0.01% of Delphi Private Advisors's portfolio in Q2 2019, its #94 holding.
105 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2019.

Based on Delphi Private Advisors's 13F filing for Q2 2019, filed 17 Jul 2019.